Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 361-380 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 361 | Romanian InSpace Engineering lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources only provides older membership context that Romanian InSpace Engineering was part of the consortium that developed the EMISAR satellite via article; that is insufficient for a current positive thesis within this ranking window. Why now: No why-now catalyst is evidenced because there are no retained 90-day evidence. Caveats: Reviewed evidence references but provides no. Single historical membership-support mention only. No retained evidence after recent evidence window. |
| 362 | Safran lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources does not provide direct positive company-specific evidence within the available 90-day evidence set. Only older or contextual references are cited in the membership rationale, including thematic propulsion or battery market reports and a reference to expanded small-satellite propulsion manufacturing, but no direct post-recent evidence window evidence is available for scoring. Why now: There is no current catalyst in the reviewed sources. Coverage debug shows 270 article IDs considered but 0 article IDs after recent evidence window and 0 evidence available after dedupe, so recency-based thesis formation is not supported. Caveats: Membership rationale references article IDs 2026-04, and, but no are provided in the reviewed sources, so they cannot be cited as factual scoring evidence under the the evidence standard. Evidence recent evidence review shows 0 kept rows after the 90-day cutoff. |
| 363 | SatLeo Labs lowweak | Opp 1 Risk 1 | Thesis: Reviewed evidence rationale says SatLeo Labs raised seed funding for a multispectral and thermal Earth observation constellation, but no retained article/evidence are available here to support a stronger opportunity ranking. Why now: No retained within the recent evidence window evidence are provided, so there is no reviewed sources-supported why-now beyond cohort inclusion rationale. Caveats: Only membership rationale is available; no citeable retained evidence. Small-company universe but zero available evidence after recent evidence window. |
| 364 | SciTec lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources say AI software came from a SciTec subsidiary in connection with Firefly's lunar imaging service, but this is only supporting article context without retained direct evidence, so it does not support a strong long-horizon opportunity thesis for SciTec itself. Why now: No current catalyst is established because the reviewed sources retains no company-specific evidence after the 90-day filter. Caveats: Phase-2 rationale references, but no or retained summary is available in the reviewed sources. Support level is provisional single-article context. No direct company-specific positive or negative evidence remain after recent evidence window. |
| 365 | SEALSQ Corp lowweak | Opp 1 Risk 2 | Thesis: Reviewed evidence membership rationale says SEALSQ is directly involved with WISeSat in a planned 100-satellite QSOC constellation and post-quantum satellite launches, which could indicate long-horizon strategic relevance, but no usable direct positive evidence or article survive the 90-day served evidence set in these reviewed sources. Why now: Why now is weak because the 90-day reviewed sources contain no available evidence after recent evidence window for SEALSQ, despite article history existing in the broader corpus. Caveats: No direct positive or negative evidence available after recent evidence window. Membership rationale references article IDs and, but the reviewed sources provide no for them, so they cannot be cited as factual support under the the evidence standard. |
| 366 | SEALSQ Corp lowweak | Opp 1 Risk 1 | Thesis: Reviewed evidence context links SEALSQ to post-quantum payload development with WISeSat, but there is no retained direct positive evidence inside the 90-day recent evidence window to support a 1 year+ opportunity thesis. Why now: There is no usable current evidence because articles after recent evidence window = 0 and evidence after recent evidence window = 0 following the March 29, 2026 cutoff. Caveats: No surviving recent evidence window-qualified evidence. Space relevance in reviewed sources rationale does not establish direction. |
| 367 | SES S.A. lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources membership rationale places SES in satellite communications and infrastructure contexts, but there are no available within the recent evidence window evidence or article details to support a directional opportunity thesis for this screen. Why now: Why-now is weak because no reviewed evidence are available after recent evidence window, so recency and catalysts cannot be assessed from the reviewed sources. Caveats: Membership rationale references and, but no corresponding available article summaries or evidence are provided. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Cohort membership does not establish opportunity. |
| 368 | Sidus Space Inc. lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources' membership rationale references payload and agreement expansion activity, but no retained within the recent evidence window direct evidence or article summaries are available here to support a positive investment-style thesis. Why now: There is no retained dated company evidence after the 90-day recent evidence window; timing support for a 1 year+ thesis is absent in the reviewed sources. Caveats: Coverage is effectively empty after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. The membership rationale mentions article IDs, and, but no or retained evidence content are provided in these reviewed sources. |
| 369 | SkyFi lowweak | Opp 1 Risk 1 | Thesis: No direct positive evidence is available, so there is no supportable upside thesis from these reviewed sources alone. Why now: Membership rationale says SkyFi was mentioned as a commercial access partner for Vantor's satellite imagery constellation in article, but this is only contextual and no or direct evidence are provided. Caveats: Partner context is weaker than direct company evidence. No evidence available after recent evidence filtering. Referenced has no in the reviewed sources. |
| 370 | Skyfora lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources only says Skyfora appears in a funding roundup with a €6.5M raise, but no retained direct evidence or article summaries are provided after the 90-day recent evidence window, so there is not enough evidence to support a positive 1 year+ thesis. Why now: No within the recent evidence window company-specific catalyst is provided. The reviewed sources reports zero reviewed evidence after the 90-day cutoff for Skyfora, so recency is insufficiently grounded. Caveats: Phase-2 rationale references a €6.5M raise tied to: but no representative article, or retained evidence row is provided in these reviewed sources, so it cannot be used as direct scored evidence. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership review status is not directional proof. |
| 371 | Solestial Inc. lowweak | Opp 1 Risk 1 | Thesis: No positive thesis is supportable from these reviewed sources because no retained direct positive evidence is provided inside the recent evidence window. Why now: No current catalyst can be established from the reviewed sources; the company has zero evidence after recent evidence window. Caveats: Phase-2 rationale says York Space Systems acquired Solestial and cites: but no article summary or is provided here, so it cannot be used as cited factual support. Coverage debug shows 4 articles considered and 0 article IDs after recent evidence window. Absence of evidence is not positive or negative proof. |
| 372 | Solstar Space Company lowweak | Opp 1 Risk 1 | Thesis: The membership rationale says Solstar's Deke Space Communicator operated in orbit and achieved TRL 9 with two-way data transmission and onboard Wi-Fi, which could imply commercialization potential, but no direct positive evidence or article summaries are available for scoring in these reviewed sources. Why now: The reviewed sources contain no reviewed evidence after recent evidence window for this company, preventing a recency-based 1 year+ ranking judgment beyond watchlist status. Caveats: Membership rationale references article, but no direct summary or evidence row is available here for citation. Coverage debug shows zero available evidence after recent evidence window. Private-company status is not itself positive or negative. |
| 373 | Space Systems/Loral, LLC (SSL) lowweak | Opp 1 Risk 1 | Thesis: SSL is referenced in membership rationale as appearing among key players in an optical satellite market report, but that is only article-level industry context and no direct within the recent evidence window evidence is available. Why now: No current catalyst can be established because coverage debug shows 0 article IDs after recent evidence window and 0 evidence after recent evidence window. The rationale cites: without a in these reviewed sources. Caveats: Only industry-report context is referenced in membership rationale. No direct event/fact evidence survived the recent evidence window. |
| 374 | Space42 lowweak | Opp 1 Risk 1 | Thesis: Space42 is described in membership rationale as operating a SAR Earth observation constellation with satellites entering full operation, but the reviewed sources retains no direct evidence or article summaries within the recent evidence window to support a current opportunity ranking. Why now: Why now is weak because coverage data shows no articles after recent evidence window and no evidence after recent evidence window. Caveats: Membership rationale references article IDs but no are provided, so they cannot be used as cited factual support here. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. |
| 375 | SpaceLocker lowweak | Opp 1 Risk 1 | Thesis: There is not enough retained evidence in the recent evidence window to underwrite a durable opportunity case, despite membership rationale describing a first shared satellite mission. Why now: No article-level or event-level evidence were retained after the March 29, 2026 recent evidence window cutoff; recency for the membership rationale is therefore unusable for ranking. Caveats: Membership rationale references article, but no representative article summary or retained evidence row is included. Single-article universe with zero retained rows limits confidence materially. |
| 376 | SpaceLogistics (Northrop Grumman) lowweak | Opp 1 Risk 2 | Thesis: The reviewed sources contain a descriptive article saying SpaceLogistics provides cooperative in-orbit satellite servicing using commercial servicing vehicles, which supports strategic relevance as a business category, but the only cited article is dated March 4, 2025 and was dropped by the 90-day recent evidence window. Why now: Why now is weak because the only cited article, March 4, 2025), falls outside the 90-day recent evidence window and was dropped; recency therefore does not support an active thesis here. Caveats: No evidence were kept after recent evidence filtering. Cannot rely on dropped 2025 evidence for a current ranking. Company-category relevance is not sufficient for a directional opportunity thesis. |
| 377 | Spaceworks lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources only says Momentus's fully booked Vigoride 8 mission will carry a Spaceworks COSMIC payload, which indicates some space-payload involvement but does not establish a durable company-specific opportunity thesis for Spaceworks. Why now: No within the recent evidence window retained catalyst is available. The phase-2 rationale references, but no, timestamp, or retained summary is included. Caveats: Support is provisional single-article context only. No retained direct evidence after recent evidence window. Payload mention does not prove company-level commercial traction. |
| 378 | Spacium lowweak | Opp 1 Risk 2 | Thesis: Spacium has a potentially attractive refueling/logistics angle, and an older article says it raised an oversubscribed $6.3 million seed round, but that dated evidence is outside the 90-day recent evidence window and therefore cannot support a current-ranked opportunity thesis. Why now: The only cited article is dated January 23, 2025, and the reviewed sources explicitly shows it was dropped by the 90-day recent evidence window cutoff of March 29, 2026. Caveats: All dated evidence was excluded by recent evidence window. Do not use out-of-window article as current recency proof. |
| 379 | SSC Space lowweak | Opp 1 Risk 1 | Thesis: No positive thesis is supportable from these reviewed sources because no direct positive evidence remains after recent evidence filtering. Why now: There is no retained within the recent evidence window evidence for a current catalyst. Caveats: Phase-2 rationale mentions a sponsored article and a partnership supporting Firefly's Blue Ghost lunar lander antennas, citing, but no or article summary is provided in these reviewed sources. Coverage debug shows 3 articles considered and 0 after recent evidence window. Sponsored-article context would be weaker than direct event/fact evidence even if fully provided. |
| 380 | ST Engineering lowweak | Opp 1 Risk 1 | Thesis: Only weak, supporting article context suggests ST Engineering had involvement in SAR and AI geospatial analytics for satellite ocean surveillance, but the reviewed sources contain no direct positive evidence after the 90-day recent evidence window and no article to substantiate a durable 1 year+ opportunity thesis (: not provided in reviewed sources). Why now: There is no usable dated direct evidence inside the recent evidence window; the reviewed sources explicitly shows articles after recent evidence window = 0 and evidence after recent evidence window = 0, so recency-based timing is unsupported. Caveats: No direct evidence remained after the recent evidence filter. Representative articles are empty, so no is available in the reviewed sources. Membership rationale is weaker than company-specific event evidence. |
Risk view
Showing rows 101-120 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 101 | Portal Space Systems lowweak | Opp 4 Risk 3 | Thesis: Debris-removal and spacecraft execution risk are plausible, but the reviewed sources includes no direct negative evidence and no usable article summaries to confirm timing or traction. Why now: Potential why-now would be the reported Series A and service positioning, but recency cannot be verified because no evidence are retained after the recent evidence window. Caveats: Phase2 membership rationale references: but no article summary or evidence are included. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Slightly higher opportunity than some peers only because the reviewed sources rationale mentions both financing and product/service positioning. |
| 102 | RapidTek lowweak | Opp 5 Risk 3 | Thesis: No direct adverse evidence is present. Main risk is scaling from connectivity demonstration to operational network and customer adoption, especially since the reviewed sources contain only one supporting article and no revenue or contract evidence. Why now: Why now is the reported successful satellite-ground connection and stated LEO IoT ambition referenced in article ID, though the reviewed sources does not include the article or exact timing details. Caveats: The technical milestone is described only in membership rationale, not available direct evidence. Article ID has no in the reviewed sources. Technical connectivity milestone is weaker than contracted commercial deployment. |
| 103 | Reaction Dynamics lowweak | Opp 3 Risk 3 | Thesis: Rocket startup execution risk remains material because the reviewed sources provide no kept direct evidence on funding amount, milestone completion, engine or launch readiness, customer backlog, or follow-on capital. Why now: The support is tied to article: in the membership rationale, which suggests a relatively recent funding-related development, but the active evidence set still contains zero available rows after recent evidence filtering. Caveats: Government funding mention is promising but unquantified in the active evidence set. No chronology-confirmed operational updates are available. |
| 104 | Redwire Corporation mediummedium | Opp 6 Risk 3 | Thesis: Risk is moderate because the available evidence is still supporting article context rather than direct dated event/facts, and one duplicate/related article is undated, which weakens recency certainty. There is no available material adverse evidence, but execution and commercialization assumptions are not independently corroborated by stronger reviewed sources rows. Why now: The why-now case is the best in the set: a published June 4, 2026 article says Redwire was awarded a contract from Astrobiome Space for the inaugural flight of its commercial space greenhouse on the ISS. Earlier, on April 8, 2026, Defense Daily reported Redwire among companies awarded more than $1.8 billion total under the Andromeda SDA contracts. Those dated items suggest current business momentum that could matter over a 1 year+ horizon. Evidence
Caveats: Evidence is weak-context/supporting article context, not direct positive events. The standard-journal article carrying similar June 4, 2026 text is undated in the reviewed sources and should not be treated as independent confirmation. No material adverse evidence is available, but absence of negative evidence is not proof of low risk. |
| 105 | Sidus Space Inc. lowweak | Opp 2 Risk 3 | Thesis: Risk is slightly elevated versus some peers because the company has a larger article universe but zero retained evidence in these reviewed sources, leaving a material information gap. Without direct within the recent evidence window evidence, current contract health, financing, or execution cannot be judged. Why now: Why now is weak because although the company had 44 considered articles, the reviewed sources show articles after recent evidence window = 0 and evidence after recent evidence window = 0, so the current business state is not evidenced here. Caveats: Phase-2 membership rationale references: and: but no or available evidence are provided. A large historical article universe should not be mistaken for conviction. No within the recent evidence window direct evidence is available for ranking. |
| 106 | Sierra Nevada Corporation lowweak | Opp 3 Risk 3 | Thesis: Risk is also elevated relative to peers because the reviewed sources say stronger contract evidence concerns Sierra Space rather than Sierra Nevada Corporation, and the evidence mix may blur entity boundaries, making any thesis vulnerable to misattribution. Why now: If the referenced constellation and on-orbit transmission activity are current, they could matter over a 1 year+ horizon; however, the reviewed sources provide no available after-recent evidence window evidence to confirm recency or milestone sequence. Caveats: Phase-2 rationale references: and: but no or article summaries are included. The reviewed sources explicitly warns that the evidence mixes SNC and Sierra Space-adjacent themes. Coverage debug shows zero evidence after recent evidence window, so direct validation is unavailable. |
| 107 | Skylo Technologies lowweak | Opp 2 Risk 3 | Thesis: Main risk is evidence scarcity rather than reviewed sources-proven business deterioration. With zero reviewed evidence after the 90-day recent evidence window, there is limited support for either commercial progress or downside. Why now: There is no fresh kept article evidence after the March 29, 2026 cutoff; timing support is weak and recency is effectively absent in the ranking payload. Caveats: No evidence were kept after recent evidence window for ranking. Membership rationale is not sufficient by itself for a strong directional thesis. |
| 108 | Spacecoin lowweak | Opp 3 Risk 3 | Thesis: Risk is equally meaningful because the described model appears highly conceptual in the reviewed sources, and the evidence does not clearly establish operational satellite-communications scale, contract traction, or validated commercial milestones. Why now: If the network concept is advancing, that could be relevant over a long horizon, but the reviewed sources offers no available recency-validated milestone evidence after recent evidence window. Caveats: Phase-2 rationale references and, but no or summaries are included. Business-model adjacency to satellite communications is not the same as proven operating traction. Coverage debug shows zero evidence after recent evidence window. |
| 109 | Starfish Space mediumstrong | Opp 7 Risk 3 | Thesis: Starfish remains execution-sensitive because the thesis depends on converting funding and government-backed validation into mission delivery and scaled production, but the reviewed sources does not contain direct adverse events. Why now: The timing is favorable for a 1 year+ horizon because recent financing on April 7, 2026 was explicitly tied to executing first servicing missions and boosting production, following prior government contract momentum Evidence
Caveats: The strongest support is external web-search evidence, though it is company-linked and dated. Some contract details in weaker article context vary and should not be over-aggregated across repeated articles. |
| 110 | Synspective mediummedium | Opp 6 Risk 3 | Thesis: Risk remains moderate because the reviewed sources provide only supporting article context with neutral polarity rather than direct positive or negative events, and some support is company-sourced, so execution, demand conversion, and economic durability are not independently validated here Why now: The recency stack is favorable for a 1 year+ thesis: May 1, 2026 launch progress, May 21, 2026 operating-profile context, and June 3, 2026 alliance expansion together suggest that constellation buildout and service-capability scaling were active in the most recent recent evidence window period Evidence
Caveats: Evidence is supporting article context and mostly neutral-polarity in reviewed sources structure, not direct dated event/facts. Two key supportive items are company-sourced pages/press releases. No retained adverse evidence exists, but absence of bad news is not proof of low risk. |
| 111 | TakeMe2Space mediummedium | Opp 7 Risk 3 | Thesis: The reviewed sources contain no direct negative evidence; risk is mainly that the evidence is still supporting article context rather than a more detailed direct event/fact trail on disbursement timing, commercial conversion, or technical milestones. Why now: The IN-SPACe funding article is dated June 12, 2026, very recent within the recent evidence window, and describes first investment into selected Indian spacetech startups including TakeMe2Space, which could shape the next year of development. Source date: June 12, 2026 Evidence
Caveats: Reviewed evidence notes prior broader membership support, but only one in-window article context is retained here. Evidence is supporting article context only despite stronger historical support counts. |
| 112 | Telesat Corporation lowweak | Opp 2 Risk 3 | Thesis: Risk stems from lack of current supporting evidence around rollout progress in these reviewed sources rather than any direct adverse event. Why now: No within the recent evidence window evidence were available for Telesat Corporation, so there is no current evidence-set-backed catalyst despite the membership rationale referencing future constellation timing. Caveats: Membership rationale references article IDs and, but their contents are not included here for direct citation. Evidence recent evidence review shows 0 kept rows after the 90-day cutoff. As a result, scores are necessarily conservative. |
| 113 | ThinkOrbital lowweak | Opp 4 Risk 3 | Thesis: Risk is moderate because the reviewed sources provide only article-level company website context, with no direct contracts, funding, launches, or customer wins in the retained evidence. Product ambition is clearer than commercial proof. Why now: Why now is the dated company-context article from May 28, 2026, recent within the recent evidence window, but it is still weak grounding because it is article-level website context rather than a confirmed business event. Evidence
Caveats: Evidence is article-level website context, not direct contract or financing evidence. Single-source evidence limits corroboration. No dated proof of revenue, customer adoption, or deployment is included. |
| 114 | Turion Space lowweak | Opp 3 Risk 3 | Thesis: No direct negative evidence is included; risk is mostly uncertainty from missing current corroboration rather than adverse developments. Why now: No within the recent evidence window evidence was available in these reviewed sources, so the timing case is weak despite the strategic framing in the membership rationale. Caveats: Membership rationale references article IDs and, but no article content is provided here for citation. Evidence recent evidence review shows 0 kept rows. Scores remain conservative because the reviewed sources lack usable direct evidence. |
| 115 | Ulook lowweak | Opp 2 Risk 3 | Thesis: Primary risk is execution and evidence opacity rather than a documented adverse event. The reviewed sources contain no direct negative evidence, but also no available positive event/fact evidence after recent evidence window, leaving material uncertainty around financing, milestones, and traction. Why now: Why now is weak because the reviewed sources show two articles were considered for membership support, yet zero article context or evidence were available after recent evidence window; recency and milestone timing are therefore uncertain. The membership rationale references article IDs and, but no or article dates were provided in the reviewed sources. Caveats: No direct positive or negative evidence were provided after recent evidence window. Membership rationale references article IDs and, but no are available, so those claims cannot be fully cited under the the evidence standard. Opportunity score is kept low because membership is not thesis attractiveness. |
| 116 | UNASTELLA Corporation mediummedium | Opp 6 Risk 3 | Thesis: No direct adverse evidence is provided, but as a rocket startup the reviewed sources only gives article-level funding context without additional confirmation on milestones, contracts, or operating traction, leaving execution risk high relative to evidence depth. Why now: The funding context is dated June 1, 2026 and sits well within the 90-day recent evidence window, making it recent enough to support a 1 year+ development runway thesis. Source date: June 1, 2026 Evidence
Caveats: Evidence is from a LinkedIn space briefing and is supporting article context only. No direct product milestone, customer, or contract evidence is available. |
| 117 | Vast, Inc. lowweak | Opp 3 Risk 3 | Thesis: Commercial space station development is inherently execution-intensive, but these reviewed sources includes no direct adverse evidence within the recent evidence window. Why now: Why-now is unproven from these reviewed sources because no dated evidence survived the 90-day recent evidence window despite 11 articles considered. Caveats: Phase2 membership rationale references and, but no summaries or evidence are available for citation. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Scores remain near low baseline due to absence of directly citable local evidence. |
| 118 | Voyager Space mediummedium | Opp 6 Risk 3 | Thesis: Risk is moderate rather than low because most of the evidence is supporting article context, not positive evidence, and part of the recent award activity is defense-oriented rather than directly proving commercial space monetization breadth Why now: The timing is comparatively favorable: Voyager has dated within the recent evidence window evidence published May 26, 2026 for a $16.5M DARPA Phase 2 contract, May 29, 2026 defense/national security capability context, and June 4, 2026 current company capability context, all within the reviewed sources recent evidence window and relevant to a 1 year+ horizon Evidence
Caveats: Much of the evidence is supporting article context rather than direct positive rows. Some cited capability pages are company-provided materials. Ticker is absent in the required company entry even though external articles reference NYSE: VOYG; this output preserves the required ticker field from the input. |
| 119 | Voyager Technologies, Inc. lowweak | Opp 3 Risk 3 | Thesis: The absence of fresh evidence is itself the main risk for ranking purposes: there is no available adverse event, but also no post-recent evidence window proof of progress on a capital-intensive program, leaving the name unrankable beyond a low-conviction watchlist stance. Why now: No current catalyst is evidenced in the reviewed sources. Although membership support references article IDs and, the reviewed sources show 0 article IDs after recent evidence window and 0 evidence after recent evidence window, so business-state recency cannot be established. Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article IDs and, but the reviewed sources provide no or article summaries for citation. |
| 120 | VyomIC lowweak | Opp 4 Risk 3 | Thesis: The same rationale points to long-dated milestones, with first satellites planned for 2027 and 2028, implying material schedule, financing, and execution risk over the forecast horizon. No direct negative event is available, but the business appears early-stage from the reviewed sources. Why now: Why now is moderate only because the business is framed around future constellation deployment and milestone timing beyond the immediate term; however, recency cannot be validated because no recent evidence window evidence are available. Caveats: Membership rationale cites article IDs and, but no are present. No representative article text or direct event/facts are available after the 90-day recent evidence window. Scoring reflects early-stage optionality and execution risk, not direct verified traction. |